Most major insurance plans, Medicare, and Medicaid cover Spravato treatment when administered at certified centers like ours. Our dedicated team handles all the paperwork, prior authorization, and insurance coordination so you can focus on your recovery.
The good news is that Spravato is widely covered by insurance when you receive treatment at a REMS-certified facility like our New Jersey centers. After working with hundreds of patients since 2019, we've successfully secured coverage through virtually every major insurance provider.
The key requirement is that treatment must be administered at a certified Spravato treatment center with proper REMS certification—which all of our New Jersey locations maintain. Insurance companies recognize the value of this breakthrough treatment, especially considering the high costs of treatment-resistant depression through emergency visits, hospitalizations, and ongoing ineffective treatments.
Most insurance plans require prior authorization before approving Spravato treatment, but here's what sets us apart: our experienced team manages this entire process for you. With almost 20,000 treatments administered, we know exactly what documentation insurance companies need and how to present your case for the fastest approval.
Our Prior Authorization Process:
When you have your initial consultation, our insurance specialists immediately begin working on your behalf. We gather all necessary medical records, document your treatment history with traditional antidepressants, and compile the clinical evidence that demonstrates your need for Spravato therapy. Most prior authorizations are approved within 3-5 business days.
What We Document for Insurance:
- Your history of treatment-resistant depression
- Previous antidepressant trials and their outcomes
- Clinical assessment showing moderate to severe depression scores
- Medical necessity based on FDA-approved criteria
- Our physician's treatment recommendation and monitoring plan
You don't need to worry about medical codes, insurance forms, or follow-up calls. Our team has developed streamlined relationships with all major insurance providers, and we know how to navigate their specific requirements. If an initial request is denied, we immediately file appeals with additional supporting documentation—and we don't stop until we get you approved!
Even with insurance coverage, it's important to understand what you might pay out-of-pocket. The good news is that most patients find Spravato treatment surprisingly affordable, especially when you consider the life-changing results and compare it to the ongoing costs of ineffective treatments.
Typical Out-of-Pocket Expenses:
Copayments: Usually range from $25-$40 per treatment session
Coinsurance: You may be responsible for 10-30% of the treatment cost after meeting your deductible
Deductible: If you haven't met your annual deductible, this may apply to your first few treatments
The SpravatoWithMe Savings Program:
Here's where costs become even more manageable. Janssen, the manufacturer of Spravato, offers the SpravatoWithMe program that can reduce your out-of-pocket costs to as little as $10 per treatment for eligible patients. Our team automatically processes this paperwork for qualified patients, often covering your coinsurance portion entirely.
Real Cost Example:
One of our patients with Blue Cross Blue Shield insurance had a $35 copay per session. Through the SpravatoWithMe program, her actual cost dropped to $10 per treatment. Over her 8-week induction period (16 treatments), she paid just $160 instead of $560.
Medicare and Medicaid Patients:
Medicare Part B typically covers 80% of the treatment cost, with your supplemental insurance often covering the remaining 20%. Medicaid patients generally have no out-of-pocket costs, and we help coordinate transportation assistance when needed.
Don't let insurance questions delay your path to relief. Our experienced team can verify your Spravato coverage and begin the prior authorization process within 24 hours of your call. With our 97%+ approval success rate, chances are excellent that your treatment will be covered.
Our REMS-certified specialists will verify your insurance coverage, assess your eligibility for Spravato treatment, and answer any questions about the process. Most screenings are completed within 24 hours, with same-day appointments available for qualified candidates.
You may have heard about other ketamine-based depression treatments like IV ketamine infusions or at-home ketamine services (Mindbloom, HelloInnerWell). While these share similar mechanisms, there's a crucial difference: insurance coverage.
Why Insurance Covers Spravato But Not Other Options:
Spravato is the only FDA-approved ketamine-based treatment specifically for treatment-resistant depression. This approval came after rigorous clinical trials and safety studies that other ketamine treatments haven't completed. Insurance companies recognize this evidence-based approach and the REMS safety protocols required for Spravato administration.
The Bottom Line:
While other ketamine treatments require you to pay thousands out-of-pocket with no guarantee of insurance reimbursement, Spravato offers the same breakthrough NMDA mechanism with full insurance support and comprehensive medical supervision.
with insurance coverage, full medical supervision.
8-week Spravato induction: $160-$640 with insurance
Ongoing maintenance: $40-$160/month with insurance
completely out-of-pocket (not FDA-approved for depression).
4-week induction: $3200
$6,400-$12,800/year for IV ketamine maintenance treatment.
with absolutely no insurance coverage, limited medical supervision.
$1,254 for 6 ketamine sessions
$90-150 per ongoing weekly treatment
We believe that financial barriers should never prevent someone from getting life-saving depression treatment. Beyond insurance coverage and manufacturer savings programs, we offer multiple pathways to make Spravato treatment accessible for every patient who needs it.
Our Financial Support Options:
- Extended payment arrangements that break costs into manageable monthly payments
- Hardship assistance programs for patients facing temporary financial difficulties
- Coordination with Janssen Patient Assistance treatment program that can bring down the cost of treatment to zero
Why This Investment Makes Financial Sense:
Patients with treatment-resistant depression typically spend thousands annually on:
- Multiple doctor visits and specialist consultations
- Emergency room visits during crisis episodes
- Psychiatric hospitalizations (average cost: $8,000-$12,000 per stay)
- Lost income from missed work days
Real Patient Impact:
Studies show that patients who respond well to Spravato have 32% lower total healthcare costs in the six months following treatment compared to non-responders. Many of our patients return to work, reduce their need for crisis interventions, and dramatically improve their quality of life—making the treatment investment one of the best decisions they've ever made.
Our Commitment:
As we've said since 2006, we put patients above profits. Our mission is to remove every possible barrier—including financial ones—that might prevent you from getting the depression care you need. If insurance approval or cost is a concern, speak with our team. We'll work with you to find a winning solution.
When traditional treatments haven't brought relief, hope can feel distant. Our experienced team has helped nearly 20,000 patients find breakthrough relief with Spravato.
Your journey to feeling like yourself again starts with one conversation. Call today - most insurance plans accepted.